-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UIKvMT5A/PQAY8B9kUwni2JunHKICMwzY6Lhl7E09OjC+JQ7ejvBTj7PMlzRUrd+ qBScmZ1A1ta6xxrgFVDrKA== 0001013594-00-000234.txt : 20001205 0001013594-00-000234.hdr.sgml : 20001205 ACCESSION NUMBER: 0001013594-00-000234 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20001130 FILED AS OF DATE: 20001204 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: VION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000944522 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133671221 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: SEC FILE NUMBER: 000-26534 FILM NUMBER: 782747 BUSINESS ADDRESS: STREET 1: 4 SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 2034984210 MAIL ADDRESS: STREET 1: FOUR SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 FORMER COMPANY: FORMER CONFORMED NAME: ONCORX INC DATE OF NAME CHANGE: 19950615 COMPANY DATA: COMPANY CONFORMED NAME: ELLIOTT ASSOCIATES LP CENTRAL INDEX KEY: 0000904495 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] OWNER IRS NUMBER: 222140975 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: 712 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2125062999 MAIL ADDRESS: STREET 1: ELLIOTT ASSOCIATES LP STREET 2: 712 5TH AVE CITY: NEW YORK STATE: NY ZIP: 10019 4 1 0001.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP [ ] Check box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) FORM 4 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 1. Name and Address of Reporting Person Westgate International, L.P. c/o HSBC Financial Services (Cayman) Limited P.O. Box 1109, Mary Street Grand Cayman, Cayman Islands, BWI 2. Issuer Name and Ticker Trading Symbol Vion Pharmaceuticals, Inc. (VION) 3. IRS or Social Security Number of Reporting Person (Voluntary) 4. Statement for (Month/Day/Year) 11/00 5. If Amendment, Date of Original (Month/Year) 6. Relationship of Reporting Person to Issuer (Check all applicable) [ ] Director [ ] Officer (give title below) [ ] Chairman [x] 10% Owner [ ] Other (specify below) 7. Individual or Joint/Group Filing (Check applicable line) [x] Form filed by one Reporting Person [ ] Form filed by more than one Reporting Person (Page 1 of 3) Table I Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) (a), (b) and (c) Common Stock 2. Transaction Date (Month/Day/Year) (a) 11/29/00 (b) 11/30/00 (c) 11/30/00 3. Transaction Code (Inst. 8) (a) P (b) P (c) P V 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) Amount: (a) 3,750 (b) 8,000 (c) 12,500 (A) or (D): (a) A (b) A (c) A Price: (a) $6.97 (b) $7.53 (c) $7.69 5. Amount of Securities Beneficially Owned at End of Month (Instr. 3 and 4) (a), (b) and (c) 1,452,019 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) (a), (b) and (c) D 7. Nature of Indirect Beneficial Ownership (Instr. 4) Not applicable Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. (Page 2 of 3) Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g. puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercisable Price of Derivative Security 3. Transaction Date (Month/Day/Year) 4. Transaction Code (Instr. 8) Code V 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) (A) (D) 6. Date Exercisable and Expiration Date (Month/Day/Year) Date Exercisable: Expiration Date: 7. Title and Amount of Underlying Securities (Instr. 3 and 4) Title: Amount: 8. Price of Derivative Security (Inst. 5) 9. Number of Derivative Securities Beneficially Owned at End of Month (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Explanation of Responses: *Intentional misstatement or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). WESTGATE INTERNATIONAL, L.P. By: Elliott International Capital Advisors, Inc., as Attorney-in-fact By: /s/ Elliot Greenberg December 4, 2000 Elliot Greenberg, Vice President Date *Signature of Reporting Person (Page 3 of 3) -----END PRIVACY-ENHANCED MESSAGE-----